Navigation Links
FASEB announces 2014 Science Research Conference: Molecular Biophysics of Membranes
Date:1/22/2014

Bethesda, MD This 2014 FASEB Science Research Conference will focus on the basic biophysical and structural principles underlying the structure and function of membranes and membrane proteins. Topics that will be represented at the 2014 meeting include interfacially active peptides, membrane fusion, membrane proteases and their products in disease, membrane protein structure, function and folding.

This year's meeting will also include sessions that focus on membrane biotechnology and bioinformatics. A principal objective of this meeting is to stimulate cross-pollination of ideas amongst a diverse group of membrane biophysicists, cell biologists, biochemists, as well as structural and computational biologists by bringing them together in an intimate setting to share the latest developments in their fields, and in related fields. Furthermore, by involving junior faculty as well as established faculty, and by selecting multiple short oral presentations from the submitted abstracts, we expose junior researchers to the group and allow them to share their insights.

Finally, we will have a "Meet the Experts" session in which prominent attendees first will speak of career choices and other relevant issues to the whole group, and then will break into small groups over lunch to be joined by students and junior faculty for lunch conversations.


'/>"/>

Contact: Robin Crawford
src@faseb.org
301-634-7010
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1

Related biology news :

1. FASEB announces 2014 SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
2. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
3. FASEB announces 2014 Science Research Conference: Retinal Neurobiology and Visual Processing
4. FASEB announces 2014 Science Research Conference: Virus Structure and Assembly
5. FASEB announces 2014 Science Research Conference: Protein Folding in the Cell
6. FASEB announces 2014 Science Research Conference: 2nd International Conference on Retinoids
7. FASEB announces SRC: Molecular Mechanisms of Intestinal Lipid Transport & Metabolism
8. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
9. FASEB announces 2014 SRC: Protein Interactions, Structures, Technologies & Networks
10. FASEB announces 2014 Science Research Conference: Biology & Pathobiology of Krueppel-Like Factors
11. FASEB announces BioArt image and video competition winners
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... 2017 Vigilant Solutions , a vehicle ... agencies, announced today the appointment of retired FBI special ... safety business development. Mr. Sheridan brings more ... a focus on the aviation transportation sector, to his ... Mr. Sheridan served as the Aviation Liaison Agent Coordinator ...
(Date:3/13/2017)... Germany , March 13, 2017 Future of security: ... ... DERMALOGs Face Matching enables to match face ... forms the basis to identify individuals. (PRNewsFoto/Dermalog Identification Systems) ... DERMALOG,s "Face Matching" is the fastest software for biometric ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... allografts and patent-protected processes to develop and market advanced ... today  that it will present at the Needham Healthcare ... Parker H. "Pete" Petit, Chairman and CEO, Michael ... Cashman , EVP and Chief Commercialization Officer, and ...
(Date:3/24/2017)... 2017   Sienna Biopharmaceuticals, Inc. , a privately ... that Richard Peterson will join the company ... Peterson, who brings more than two decades of global ... is retiring at the end of April but will ... joins Sienna from Novan, Inc., where he served as ...
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
Breaking Biology Technology: